Femasys Inc (FEMY): Capital Expenditures
$525.0K
Year ended 2025-12-31
$422.7K
Trailing 12 months to 2026-06-30
+8.8%
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $525.0K | -31.1% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $761.7K | +429.3% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $143.9K | -64.7% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $407.5K | +32.8% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $306.9K | n/m | 2023-07-24, From 2021-01-01 |
| 2020-12-31 | $8.4K | n/a | 2022-03-24, From 2020-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Femasys Inc (FEMY) | 2025-12-31 | $525.0K | -31.1% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $5.2K | -2.6% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $3.68M | n/m |
| Nuo Therapeutics, Inc. (AURX) | 2025-12-31 | $274.8K | +77.3% |
| IceCure Medical Ltd. (ICCM) | 2025-12-31 | $36.0K | -49.3% |
| Tenon Medical, Inc. (TNON) | 2025-12-31 | $273.0K | +46.8% |
| Intelligent Bio Solutions Inc. (INBS) | 2026-06-30 | $125.7K | -45.8% |
| PetVivo Holdings, Inc. (PETV) | 2026-03-31 | $7.7K | -87.8% |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $2.0K | -83.3% |
Compare FEMY, VYCO, NONE., AURX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗